Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Samaille

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Bulletin Du Cancer|November 8, 2024
[Claudine 18.2: A new therapeutic target in digestive cancers]Laure Blondet, Baptiste Cervantes, Florence Renaud, et al.
Bulletin Du Cancer|March 12, 2026
[Therapeutic de-escalation strategies in the use of anti-PD-1 and anti-PD-L1: Dose, frequency, and duration]Lila Philipps, Léo Mas, Thomas Samaille, et al.
Bulletin Du Cancer|March 12, 2026
[Pancreatic acinar cell carcinoma: Clinical and theranostic characteristics]Andrea Marques, Léo Mas, Antoine Dardenne, et al.
Plos One|November 16, 2012
Contrast-based fully automatic segmentation of white matter hyperintensities: method and validationThomas Samaille, Ludovic Fillon, Rémi Cuingnet, et al.
Neuroimage|August 24, 2014
2D harmonic filtering of MR phase images in multicenter clinical setting: toward a magnetic signature of cerebral microbleedsTakoua Kaaouana, Ludovic de Rochefort, Thomas Samaille, et al.
The Oncologist|July 16, 2024
A novel risk classification model integrating CEA, ctDNA, and pTN stage for stage 3 colon cancer: a post hoc analysis of the IDEA-France trialThomas Samaille, Antoine Falcoz, Romain Cohen, et al.
Clinical Colorectal Cancer|June 12, 2026
Dual CTLA-4/PD-1 Blockade Versus Anti-PD-1 in MSI-H Metastatic Colorectal Cancer: Early Survival Benefit and Exploratory Clinical PredictorsLea Jehanno, Julie Henriques, Thomas Samaille, et al.
International Journal of Cancer|December 29, 2025
Organ-sparing strategies in patients with MSI/dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision-makingMartin Duval, Antoine Dardenne, Thomas Samaille, et al.
JCO Oncology Practice|March 26, 2026
Toxicity of Capecitabine and Oxaliplatin as Adjuvant Therapy for Stage III Colorectal Cancer Patients With Diverting StomaAndrea Marques, Julie Henriques, Dewi Vernerey, et al.
European Journal of Cancer (Oxford, England : 1990)|November 20, 2025
Patterns of progressive disease in patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer treated with immune checkpoint inhibitor(s): Different entities requiring tailored managementBaptiste Cervantes, Clément Grosnon, Thomas Samaille, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Bulletin Du Cancer|November 8, 2024
[Claudine 18.2: A new therapeutic target in digestive cancers]Laure Blondet, Baptiste Cervantes, Florence Renaud, et al.
Bulletin Du Cancer|March 12, 2026
[Therapeutic de-escalation strategies in the use of anti-PD-1 and anti-PD-L1: Dose, frequency, and duration]Lila Philipps, Léo Mas, Thomas Samaille, et al.
Bulletin Du Cancer|March 12, 2026
[Pancreatic acinar cell carcinoma: Clinical and theranostic characteristics]Andrea Marques, Léo Mas, Antoine Dardenne, et al.
Plos One|November 16, 2012
Contrast-based fully automatic segmentation of white matter hyperintensities: method and validationThomas Samaille, Ludovic Fillon, Rémi Cuingnet, et al.
Neuroimage|August 24, 2014
2D harmonic filtering of MR phase images in multicenter clinical setting: toward a magnetic signature of cerebral microbleedsTakoua Kaaouana, Ludovic de Rochefort, Thomas Samaille, et al.
The Oncologist|July 16, 2024
A novel risk classification model integrating CEA, ctDNA, and pTN stage for stage 3 colon cancer: a post hoc analysis of the IDEA-France trialThomas Samaille, Antoine Falcoz, Romain Cohen, et al.
Clinical Colorectal Cancer|June 12, 2026
Dual CTLA-4/PD-1 Blockade Versus Anti-PD-1 in MSI-H Metastatic Colorectal Cancer: Early Survival Benefit and Exploratory Clinical PredictorsLea Jehanno, Julie Henriques, Thomas Samaille, et al.
International Journal of Cancer|December 29, 2025
Organ-sparing strategies in patients with MSI/dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision-makingMartin Duval, Antoine Dardenne, Thomas Samaille, et al.
JCO Oncology Practice|March 26, 2026
Toxicity of Capecitabine and Oxaliplatin as Adjuvant Therapy for Stage III Colorectal Cancer Patients With Diverting StomaAndrea Marques, Julie Henriques, Dewi Vernerey, et al.
European Journal of Cancer (Oxford, England : 1990)|November 20, 2025
Patterns of progressive disease in patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer treated with immune checkpoint inhibitor(s): Different entities requiring tailored managementBaptiste Cervantes, Clément Grosnon, Thomas Samaille, et al.
Pageof 2